Results 71 to 80 of about 172,191 (165)

Determining the salivary levels of Transforming Growth Factor Beta 1 (TGF-β1) and Vascular Endothelial Growth Factor (VEGF) during the three stages of orthodontic treatment in patients in Mangaluru: A prospective study. [PDF]

J Orthod Sci
Catherine S, Harshitha V, Surendran S, Shetty P, Agni MLB, Rao J, Kumar K.   +6 more
europepmc   +1 more source

Neuronally-Derived Extracellular Vesicles Transforming Growth Factor Beta-1 Levels in Progressive Supranuclear Palsy. [PDF]

Mov Disord
Mimmi S, Parrotta EI, Tolomeo AM, Maisano D, Crapella V, Pingitore E, Fatima K, Zimbo AM, Talarico M, Cristiani CM, Scaramuzzino L, Valente D, Zannino C, Cuda G, Quattrone A, Iaccino E, Quattrone A.   +16 more
europepmc   +1 more source

Recent advances in therapeutic use of transforming growth factor-beta inhibitors in cancer and fibrosis. [PDF]

Front Oncol
Jing H, Gao Y, Jing L, Yang H, Liu S.
europepmc   +1 more source

Correlation Between Blood Transforming Growth Factor-Beta 1 (TGF-β1) Levels and Cardiac Function Parameters Following Doxorubicin Chemotherapy. [PDF]

Cureus
Yazid M, Lnu M, Koesnoe S, Rinaldi I, Winston K, Putra D.   +5 more
europepmc   +1 more source

Transforming growth factor-beta is increased in sputum from individuals with rheumatoid arthritis-associated pulmonary fibrosis. [PDF]

Rheumatology (Oxford)
Wilson TM, Bolt M, Stahly A, Lee JS, Bang TJ, Sachs PB, Deane KD, Humphries SM, Solomon JJ, Demoruelle MK.   +9 more
europepmc   +1 more source

Evaluation of the effects of dimethyl fumarate on transforming growth factor beta levels in the liver of rats with bile duct ligation-induced cholestasis. [PDF]

Toxicol Rep
Vossoughi H, Mortazavi P, Ale-Ebrahim M, Hosseini R.   +3 more
europepmc   +1 more source

Temporal- and concentration-dependent effects of transforming growth factor-beta 1 (TGF-β1) in primary human knee fibroblasts. [PDF]

Bone Joint Res
Dilger OB, Carstens MF, Garrett DJ, Berry DJ, Sanchez-Sotelo J, Morrey ME, Thaler R, Dudakovic A, Abdel MP.   +8 more
europepmc   +1 more source

NADPH oxidase 1/4 dual inhibition impairs transforming growth factor-beta protumorigenic effects in cholangiocarcinoma cancer-associated fibroblasts. [PDF]

Signal Transduct Target Ther
Amengual J, Gonzalez-Sanchez E, Yáñez-Bartolome M, Sererols-Viñas L, Ravichandra A, Guiton C, Fuste NP, Alay A, Hijazo-Pechero S, Martín-Mur B, Gut M, Esteve-Codina A, Cantos-Cortes A, Espinosa-Sotelo R, Ramos E, Serrano T, Calvo M, Laquente B, Ferrer J, Pons G, Mendez-Lucas A, Dooley S, Ilyas SI, Vallette M, Aoudjehane L, Lequoy M, Fouassier L, Coulouarn C, Affò S, Scheiter A, Calvisi DF, Tian TV, Fabregat I, Vaquero J.   +33 more
europepmc   +1 more source

MiR-378 mediates the ovariectomy induced bone loss via exaggerating osteoclastogenesis and transforming growth factor beta impaired osteogenesis. [PDF]

Genes Dis
Feng L, Yang Z, Hou N, Wang H, Bai S, Lu X, Wang Y, Lin S, Tortorella MD, Li G.   +9 more
europepmc   +1 more source

Hydrogen sulfide ameliorates peritoneal fibrosis: inhibition of high mobility group box-1 expression to block the activation of the transforming growth factor-beta/Smad3 pathway. [PDF]

Med Gas Res
Liu L, Huang W, Ming J, Cai F, Wang H, Lai X, Guo Z.   +6 more
europepmc   +1 more source